Journal Home > Volume 28 , Issue 3

Chronic obstructive pulmonary disease (COPD) is a serious chronic respiratory disease. Improving the ability to identify patients with COPD in primary medical institutions is important to prevent and treat the disease. With the continuous development of medical digitization, the application of big data informatization in the medical and health fields has become possible. Recently, applying innovative technologies such as big data analysis, machine learning, and artificial intelligence-assisted decision-making in the medical field has become an interdisciplinary research hotspot. Based on the identification and diagnosis of COPD in the high-risk population, this study proposes a convenient and effective clinical decision support system to help identify patients with COPD in primary health institutions. The results of the preliminary experiments show that the proposed method is convenient and effective compared with the existing methods.


menu
Abstract
Full text
Outline
Electronic supplementary material
About this article

A Case-Finding Clinical Decision Support System to Identify Subjects with Chronic Obstructive Pulmonary Disease Based on Public Health Data

Show Author's information Xinshan Lin1,5Yi Lei2Jun Chen3Zhihui Xing3Ting Yang1,5( )Qing Wang4( )Chen Wang1,5( )
Department of Pulmonary and Critical Care Medicine, China-Japan Friendship Hospital, Beijing 100029, China
School of Software Engineering, the Faculty of Information Technology, Beijing University of Technology, Beijing 100124, China
Intelligent Healthcare Unit, Baidu Inc, Beijing 100093, China
Department of Automation, Tsinghua University, Beijing 100084, China
Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100005, China

Abstract

Chronic obstructive pulmonary disease (COPD) is a serious chronic respiratory disease. Improving the ability to identify patients with COPD in primary medical institutions is important to prevent and treat the disease. With the continuous development of medical digitization, the application of big data informatization in the medical and health fields has become possible. Recently, applying innovative technologies such as big data analysis, machine learning, and artificial intelligence-assisted decision-making in the medical field has become an interdisciplinary research hotspot. Based on the identification and diagnosis of COPD in the high-risk population, this study proposes a convenient and effective clinical decision support system to help identify patients with COPD in primary health institutions. The results of the preliminary experiments show that the proposed method is convenient and effective compared with the existing methods.

Keywords: artificial intelligence, machine learning, case finding, chronic obstructive pulmonary disease (COPD), clinical decision support system (CDSS)

References(29)

[1]
W. Li, T. Yang, and C. Wang, Current status and progress of prevention and treatment of chronic obstructive pulmonary disease in China, (in Chinese), J. Chin. Res. Hosp., vol. 7, no. 5, pp. 78–84, 2020.
[2]
C. Wang, J. Y. Xu, L. Yang, Y. J. Xu, X. Y. Zhang, C. X. Bai, J. Kang, P. X. Ran, H. H. Shen, F. Q. Wen, et al., Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): A national cross-sectional study, Lancet, vol. 391, no. 10131, pp. 1706–1717, 2018.
[3]
S. Haroon, R. E. Jordan, D. A. Fitzmaurice, and P. Adab, Case finding for COPD in primary care: A qualitative study of the views of health professionals, Int. J. Chron. Obstruct. Pulmon. Dis., vol. 10, pp. 1711–1718, 2015.
[4]
National Health Commission of the People’s Republic of China, Healthy China initiative (2019–2030), (in Chinese), http://www.nhc.gov.cn/guihuaxxs/s3585u/201907/e9275fb95d5b4295be8308415d4cd1b2.shtml, 2019.
[5]
World Health Organization, Projections of mortality and causes of death, 2016 and 2060, http://www.who.int/healthinfo/global_burden_disease/projections/en/, 2020.
[6]
A. Kaplan and M. Thomas, Screening for COPD: The gap between logic and evidence, Eur. Respir. Rev., vol. 26, no. 143, p. 160113, 2017.
[7]
National Health Commission of the People’s Republic of China, Work plan for monitoring chronic diseases and nutrition in the Chinese population (trial), http://www.chinanutri.cn/tzgg_6537/tzgg_102/201412/t2014123_108847.html, 2014.
[8]
D. Y. Zhang, Y. Gao, W. H. Jian, M. Yao, J. P. Zheng, and N. S. Zhong, Feasibility and suggestions on the promotion of pulmonary function test in primary health care institutions, (in Chinese), Chin. Gen. Prac., vol. 23, no. 29, pp. 3638–3643, 2020.
[9]
K. L. Hon, E. Leung, J. L. Tang, C. M. Chow, T. F. Leung, K. L. Cheung, and P. C. Ng, Premorbid factors and outcome associated with respiratory virus infections in a pediatric intensive care unit, Pediatr. Pulmonol., vol. 43, no. 3, pp. 275–280, 2008.
[10]
Y. Gao and J. P. Zheng, Develop standardized lung function training to help prevent and control chronic respiratory diseases, (in Chinese), Chin. J. Pract. Intern. Med., vol. 39, no. 5, pp. 481–484, 2019.
[11]
R. E. Jordan, P. Adab, A. Sitch, A. Enocson, D. Blissett, S. Jowett, J. Marsh, R. D. Riley, M. R. Miller, B. G. Cooper, et al., Targeted case finding for chronic obstructive pulmonary disease versus routine practice in primary care (TargetCOPD): A cluster-randomised controlled trial, Lancet Respir. Med., vol. 4, no. 9, pp. 720–730, 2016.
[12]
P. J. P. Poels, T. R. J. Schermer, R. P. Akkermans, A. Jacobs, M. Van Den Bogart-Jansen, B. J. A. M. Bottema, and C. Van Weel, General practitioners’ needs for ongoing support for the interpretation of spirometry tests, Eur. J. Gen. Pract., vol. 13, no. 1, pp. 16–19, 2007.
[13]
A. A. Montgomery, T. Fahey, T. J. Peters, C. Macintosh, and D. J. Sharp, Evaluation of computer based clinical decision support system and risk chart for management of hypertension in primary care: Randomised controlled trial, BMJ, vol. 320, no. 7236, pp. 686–690, 2000.
[14]
R. T. Sutton, D. Pincock, D. C. Baumgart, D. C. Sadowski, R. N. Fedorak, and K. I. Kroeker, An overview of clinical decision support systems: Benefits, risks, and strategies for success, NPJ Digit. Med., vol. 3, no. 1, p. 17, 2020.
[15]
D. B. Proce, D. G. Tinkelman, R. J. Nordyke, S. Isonaka, and R. J. Halbert, Scoring system and clinical application of COPD diagnostic questionnaires, Chest, vol. 129, no. 6, pp. 1531–1539, 2006.
[16]
M. Preteroti, G. A. Whitmore, K. L. Vandemheen, J. M. Fitzgerald, C. Lemière, L. P. Boulet, E. Penz, S. K. Field, S. Gupta, R. A. Mcivor, et al., Population-based case-finding to identify subjects with undiagnosed asthma or COPD, Eur. Respir. J., vol. 55, no. 6, p. 2000024, 2020.
[17]
Y. M. Zhou, S. Y. Chen, J. Tian, J. Y. Cui, X. C. Li, W. Hong, Z. X. Zhao, G. P. Hu, F. He, R. Qiu, et al., Development and validation of a chronic obstructive pulmonary disease screening questionnaire in China, Int. J. Tuberc. Lung Dis., vol. 17, no. 12, pp. 1645–1651, 2013.
[18]
C. B. Jia, K. Huang, C. Y. Zhang, F. Fang, F. Dong, X. Y. Gu, H. T. Niu, S. W. QuMu, X. X. Ren, W. Li, et al., Status survey of the diagnosis and management ability of chronic obstructive pulmonary disease in eighty cities in China, (in Chinese), Chin. J. Clin., vol. 49, no. 6, pp. 669–671, 2021.
[19]
National Health Commission of the People’s Republic of China, Work plan for basic framework and data standards for health records (trial), (in Chinese), http://www.nhc.gov.cn/wjw/gfxwj/201304/a281f9a650d644afa5f76e114074a91c.shtml, 2009.
[20]
National Health Commission of the People’s Republic of China, Guidelines on the Construction of Regional Health Information Platform Based on Health Records, http://www.nhc.gov.cn/guihuaxxs/s10741/200906/d15e616ef81d4815babc7c9fd4636a09.shtml, 2009.
[21]
R. Kohavi, A study of cross-validation and bootstrap for accuracy estimation and model selection, in Proc. 14th Int. Joint Conf. Artificial Intelligence, Montreal, Canada, 1995, pp. 1137–1143.
[22]
T. Hastie, S. Rosset, J. Zhu, and H. Zou, Multi-class AdaBoost, Stat. Interface, vol. 2, no. 3, pp. 349–360, 2009.
[23]
A. K. Sahoo, C. Pradhan, and H. Das, Performance evaluation of different machine learning methods and deep-learning based convolutional neural network for health decision making, in Nature Inspired Computing for Data Science, M. Rout, J. Rout, and H. Das, eds. Cham, Switzerland: Springer, 2020, pp. 201–212.
DOI
[24]
S. Lundberg and S. I. Lee, A unified approach to interpreting model predictions, arXiv preprint arXiv: 1705.07874, 2017.
[25]
F. J. Martinez, A. E. Raczek, F. D. Seifer, C. S. Conoscenti, T. G. Curtice, T. D’Eletto, C. Cote, C. Hawkins, and A. L. Phillips, Development and initial validation of a self-scored COPD population screener questionnaire (COPD-PS), COPD, vol. 5, no. 2, pp. 85–95, 2008.
[26]
D. Kotz, P. Nelemans, C. P. van Schayck, and G. J. Wesseling, External validation of a COPD diagnostic questionnaire, Eur. Respir. J., vol. 31, no. 2, pp. 298–303, 2008.
[27]
P. S. Bakke, E. Rönmark, T. Eagan, F. Pistelli, I. Annesi-Maesano, M. Maly, M. Meren, P. Vermeire, J. Vestbo, G. Viegi, et al., Recommendations for epidemiological studies on COPD, Eur. Respir. J., vol. 38, no. 6, pp. 1261–1277, 2011.
[28]
J. G. Hansen, L. Pedersen, K. Overvad, Ø. Omland, H. K. Jensen, and H. T. Sørensen, The prevalence of chronic obstructive pulmonary disease among Danes aged 45–84 years: Population-based study, COPD, vol. 5, no. 6, pp. 347–352, 2008.
[29]
F. A. A. Mohamed Hoesein, P. Zanen, A. P. E. Sachs, T. J. M. Verheij, J. W. J. Lammers, and B. D. L. Broekhuizen, Spirometric thresholds for diagnosing COPD: 0.70 or LLN, pre- or post-dilator values?, COPD, vol. 9, no. 4, pp. 338–343, 2012.
File
525-540ESM.pdf (106.1 KB)
Publication history
Copyright
Acknowledgements
Rights and permissions

Publication history

Received: 03 March 2022
Accepted: 07 April 2022
Published: 13 December 2022
Issue date: June 2023

Copyright

© The author(s) 2023.

Acknowledgements

This work was supported by the Major Research Program of the National Natural Science Foundation of China (No. 91843302).

Rights and permissions

The articles published in this open access journal are distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/).

Return